🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate whether a single dose QAX576 (an interleukin-13...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-12
Trial ID
NCT00584584
This study is designed to investigate the efficacy and safety of QBX258 in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01479595
This study will evaluate the safety and efficacy of QAX576 against asthma a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00598104
This study will evaluate the safety, tolerability, and mechanism of action ...
Status
Terminated
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00581997
This study is designed to evaluate the safety, pharmacodynamic and pharmaco...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-12
Trial ID
NCT00417196
Treatments Being Tested
This is a 2-part study. In the first part (Part I, 8 subjects), biopsies wi...
Status
Terminated
Location
TKL Research, Inc
Start Date
2009-06
Trial ID
NCT00987545
Treatments Being Tested
This study is designed to investigate the effects of a 12 week course of in...
Status
Completed
Location
Stanford Medical Center and Lucile Packard Children's Hospital
Start Date
2009-11
Trial ID
NCT01022970
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, pharmacokineti...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-12
Trial ID
NCT01266135
This study is designed to investigate the safety and tolerability of multip...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-07
Trial ID
NCT00940160